{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T17:30:01Z","timestamp":1793813401088,"version":"4.6.1"},"reference-count":85,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,7,22]],"date-time":"2026-07-22T00:00:00Z","timestamp":1784678400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["ibroneuroreports.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["IBRO Neuroscience Reports"],"published-print":{"date-parts":[[2026,12]]},"DOI":"10.1016\/j.ibneur.2026.07.010","type":"journal-article","created":{"date-parts":[[2026,7,24]],"date-time":"2026-07-24T07:03:03Z","timestamp":1784876583000},"page":"352-361","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Investigating the effects of chlorogenic acid on novel object recognition memory impairment, hyperlocomotion, and prefrontal BDNF expression in a sub-chronic ketamine-induced schizophrenia-like rat model"],"prefix":"10.1016","volume":"21","author":[{"given":"Anahita","family":"Bahrami","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Batool","family":"Ghorbani Yekta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anita","family":"Baghdasarians","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ibneur.2026.07.010_bib1","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.schres.2023.11.015","article-title":"The schizophrenia syndrome, circa 2024: What we know and how that informs its nature","volume":"264","author":"Tandon","year":"2024","journal-title":"Schizophr. Res."},{"issue":"1","key":"10.1016\/j.ibneur.2026.07.010_bib2","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1186\/s12888-024-06151-x","article-title":"Prevalence of schizophrenia spectrum disorders in the Lazio region, Italy: use of an algorithm based on health administrative databases","volume":"24","author":"Bargagli","year":"2024","journal-title":"BMC Psychiatry"},{"key":"10.1016\/j.ibneur.2026.07.010_bib3","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1016\/j.jpsychires.2024.08.014","article-title":"Sex difference alters the behavioral and cognitive performance in a rat model of schizophrenia induced by sub-chronic ketamine","volume":"178","author":"Samizadeh","year":"2024","journal-title":"J. Psychiatr. Res."},{"issue":"1","key":"10.1016\/j.ibneur.2026.07.010_bib4","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-025-15499-3","article-title":"Ketamine and olanzapine alter behaviour and prefrontal-cortex BDNF differentially in male and female rats","volume":"15","author":"Manooki","year":"2025","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ibneur.2026.07.010_bib5","doi-asserted-by":"crossref","DOI":"10.1016\/j.pbb.2022.173490","article-title":"The alpha(2C)-adrenoceptor antagonist JP-1302 controls behavioral parameters, tyrosine hydroxylase activity and receptor expression in a rat model of ketamine-induced schizophrenia-like deficits","volume":"221","author":"Tekin","year":"2022","journal-title":"Pharmacol. Biochem. Behav."},{"issue":"5","key":"10.1016\/j.ibneur.2026.07.010_bib6","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1002\/jdn.10109","article-title":"Effects of maternal folic acid supplementation on nuclear methyltransferase activity of adult rats subjected to an animal model of schizophrenia","volume":"81","author":"Canever","year":"2021","journal-title":"Int. J. Dev. Neurosci."},{"issue":"12","key":"10.1016\/j.ibneur.2026.07.010_bib7","first-page":"1327","article-title":"Vinpocetine halts ketamine-induced schizophrenia-like deficits in rats: impact on BDNF and GSK-3beta\/beta-catenin pathway. Naunyn Schmiedebergs Arch Pharmacol","volume":"391","author":"Ahmed","year":"2018"},{"key":"10.1016\/j.ibneur.2026.07.010_bib8","doi-asserted-by":"crossref","DOI":"10.1016\/j.pnpbp.2024.110954","article-title":"Brain-derived neurotrophic factor levels across psychiatric disorders: A systemic review and network meta-analysis","volume":"131","author":"Zou","year":"2024","journal-title":"Prog. Neuropsychopharmacol. Biol. Psychiatry"},{"issue":"5","key":"10.1016\/j.ibneur.2026.07.010_bib9","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1097\/YPG.0000000000000237","article-title":"Brain-derived neurotrophic factor and schizophrenia","volume":"29","author":"Di Carlo","year":"2019","journal-title":"Psychiatr. Genet."},{"issue":"9","key":"10.1016\/j.ibneur.2026.07.010_bib10","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1007\/s00221-025-07145-1","article-title":"A novel finding on the sex-dependent role of BDNF and GSK-3beta in the medial prefrontal cortex in pain threshold changes in a rat model of fear conditioning with respect to the effect of extinction and the time period after conditioning","volume":"243","author":"Motamedi-Manesh","year":"2025","journal-title":"Exp. Brain Res."},{"issue":"12","key":"10.1016\/j.ibneur.2026.07.010_bib11","doi-asserted-by":"crossref","first-page":"3226","DOI":"10.1007\/s11064-024-04242-5","article-title":"New Insights into Contradictory Changes in Brain-Derived Neurotrophic Factor (BDNF) in Rodent Models of Posttraumatic Stress Disorder (PTSD)","volume":"49","author":"Ghaffarzadegan","year":"2024","journal-title":"Neurochem. Res."},{"issue":"S4","key":"10.1016\/j.ibneur.2026.07.010_bib12","article-title":"The Role of BDNF-TrkB Signaling in the Pathogenesis of PTSD","volume":"2013","author":"Green","year":"2013","journal-title":"J. Depress Anxiety"},{"issue":"3","key":"10.1016\/j.ibneur.2026.07.010_bib13","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1097\/YIC.0000000000000550","article-title":"Sex-controlled differences in sertraline and citalopram efficacies in major depressive disorder: a randomized, double-blind trial","volume":"40","author":"Shamabadi","year":"2025","journal-title":"Int. Clin. Psychopharmacol."},{"issue":"3","key":"10.1016\/j.ibneur.2026.07.010_bib14","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1016\/j.pnpbp.2010.01.010","article-title":"Serum brain-derived neurotrophic factor in patients with trauma psychopathology","volume":"34","author":"Hauck","year":"2010","journal-title":"Prog. Neuropsychopharmacol. Biol. Psychiatry"},{"issue":"1","key":"10.1016\/j.ibneur.2026.07.010_bib15","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1186\/s12906-023-04107-4","article-title":"Berberine improves inhibitory avoidance memory impairment of Toxoplasma gondii-infected rat model of ketamine-induced schizophrenia","volume":"23","author":"Gholizadeh","year":"2023","journal-title":"BMC Complement. Med. Ther."},{"issue":"6","key":"10.1016\/j.ibneur.2026.07.010_bib16","doi-asserted-by":"crossref","first-page":"285","DOI":"10.9740\/mhc.2016.11.285","article-title":"Brain-derived neurotrophic factor and schizophrenia","volume":"6","author":"Goren","year":"2016","journal-title":"Ment. Health Clin."},{"issue":"1","key":"10.1016\/j.ibneur.2026.07.010_bib17","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jpsychires.2011.09.022","article-title":"The role of BDNF in the pathophysiology and treatment of schizophrenia","volume":"46","author":"Favalli","year":"2012","journal-title":"J. Psychiatr. Res."},{"key":"10.1016\/j.ibneur.2026.07.010_bib18","doi-asserted-by":"crossref","first-page":"45","DOI":"10.3389\/fpsyt.2013.00045","article-title":"BDNF and schizophrenia: from neurodevelopment to neuronal plasticity, learning, and memory","volume":"4","author":"Nieto","year":"2013","journal-title":"Front. Psychiatry"},{"issue":"4","key":"10.1016\/j.ibneur.2026.07.010_bib19","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1038\/sj.mp.4001637","article-title":"BDNF in schizophrenia, depression and corresponding animal models","volume":"10","author":"Angelucci","year":"2005","journal-title":"Mol. Psychiatry"},{"issue":"1","key":"10.1016\/j.ibneur.2026.07.010_bib20","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/S0006-8993(02)03176-1","article-title":"Brain-derived neurotrophic factor (BDNF) mRNA in rats with neonatal ibotenic acid lesions of the ventral hippocampus","volume":"956","author":"Ashe","year":"2002","journal-title":"Brain Res."},{"key":"10.1016\/j.ibneur.2026.07.010_bib21","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1196\/annals.1418.005","article-title":"Glutamate and neurotrophic factors in neuronal plasticity and disease","volume":"1144","author":"Mattson","year":"2008","journal-title":"Ann. N. Y Acad. Sci."},{"issue":"2","key":"10.1016\/j.ibneur.2026.07.010_bib22","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/j.bj.2020.01.001","article-title":"Brain-derived neurotrophic factor and mental disorders","volume":"43","author":"Lin","year":"2020","journal-title":"Biomed. J."},{"issue":"7","key":"10.1016\/j.ibneur.2026.07.010_bib23","doi-asserted-by":"crossref","DOI":"10.3390\/nu16070924","article-title":"Chlorogenic Acid: A Systematic Review on the Biological Functions, Mechanistic Actions, and Therapeutic Potentials","volume":"16","author":"Nguyen","year":"2024","journal-title":"Nutrients"},{"key":"10.1016\/j.ibneur.2026.07.010_bib24","doi-asserted-by":"crossref","DOI":"10.1016\/j.phymed.2023.154961","article-title":"Chlorogenic acids: A pharmacological systematic review on their hepatoprotective effects","volume":"118","author":"Xue","year":"2023","journal-title":"Phytomedicine"},{"issue":"1","key":"10.1016\/j.ibneur.2026.07.010_bib25","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.abb.2010.03.005","article-title":"Bioavailability of chlorogenic acids following acute ingestion of coffee by humans with an ileostomy","volume":"501","author":"Stalmach","year":"2010","journal-title":"Arch. Biochem. Biophys."},{"issue":"1-3","key":"10.1016\/j.ibneur.2026.07.010_bib26","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.ejphar.2012.05.028","article-title":"Chlorogenic acid ameliorates brain damage and edema by inhibiting matrix metalloproteinase-2 and 9 in a rat model of focal cerebral ischemia","volume":"689","author":"Lee","year":"2012","journal-title":"Eur. J. Pharmacol."},{"issue":"1-2","key":"10.1016\/j.ibneur.2026.07.010_bib27","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.jns.2007.06.028","article-title":"Chlorogenic acid, a polyphenol from Prunus domestica (Mirabelle), with coupled anxiolytic and antioxidant effects","volume":"262","author":"Bouayed","year":"2007","journal-title":"J. Neurol. Sci."},{"issue":"3","key":"10.1016\/j.ibneur.2026.07.010_bib28","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1016\/j.neuroscience.2010.05.049","article-title":"Neuroprotective effect of 3,5-di-O-caffeoylquinic acid on SH-SY5Y cells and senescence-accelerated-prone mice 8 through the up-regulation of phosphoglycerate kinase-1","volume":"169","author":"Han","year":"2010","journal-title":"Neuroscience"},{"issue":"1","key":"10.1016\/j.ibneur.2026.07.010_bib29","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-020-74866-4","article-title":"Combination of syringaresinol-di-O-beta-D-glucoside and chlorogenic acid shows behavioral pharmacological anxiolytic activity and activation of hippocampal BDNF-TrkB signaling","volume":"10","author":"Miyazaki","year":"2020","journal-title":"Sci. Rep."},{"issue":"10","key":"10.1016\/j.ibneur.2026.07.010_bib30","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1007\/s00210-019-01670-x","article-title":"Neuroprotective effect of chlorogenic acid in global cerebral ischemia-reperfusion rat model","volume":"392","author":"Kumar","year":"2019","journal-title":"Naunyn Schmiede Arch. Pharmacol."},{"issue":"7","key":"10.1016\/j.ibneur.2026.07.010_bib31","doi-asserted-by":"crossref","first-page":"2215","DOI":"10.1007\/s00394-017-1379-1","article-title":"The potential effects of chlorogenic acid, the main phenolic components in coffee, on health: a comprehensive review of the literature","volume":"56","author":"Tajik","year":"2017","journal-title":"Eur. J. Nutr."},{"issue":"3","key":"10.1016\/j.ibneur.2026.07.010_bib32","doi-asserted-by":"crossref","first-page":"260","DOI":"10.3390\/molecules21030260","article-title":"Antidepressant Potential of Chlorogenic Acid-Enriched Extract from Eucommia ulmoides Oliver Bark with Neuron Protection and Promotion of Serotonin Release through Enhancing Synapsin I Expression","volume":"21","author":"Wu","year":"2016","journal-title":"Molecules"},{"issue":"5","key":"10.1016\/j.ibneur.2026.07.010_bib33","doi-asserted-by":"crossref","first-page":"2947","DOI":"10.1039\/C8FO02599A","article-title":"Modulation of gut microbiota by chlorogenic acid pretreatment on rats with adrenocorticotropic hormone induced depression-like behavior","volume":"10","author":"Song","year":"2019","journal-title":"Food Funct."},{"key":"10.1016\/j.ibneur.2026.07.010_bib34","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1016\/j.bcp.2018.07.023","article-title":"Chlorogenic acids inhibit glutamate dehydrogenase and decrease intracellular ATP levels in cultures of chick embryo retina cells","volume":"155","author":"Domith","year":"2018","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.ibneur.2026.07.010_bib35","article-title":"Chlorogenic Acid as a Neuroprotective Agent: Enhancing Plasticity and Promoting Brain Health and Functional Reserve","author":"Hernandez-Echeagaray","year":"2025","journal-title":"CNS Neurol. Disord. Drug. Targets"},{"issue":"7","key":"10.1016\/j.ibneur.2026.07.010_bib36","doi-asserted-by":"crossref","DOI":"10.3390\/ijms26073108","article-title":"Neuroprotective effects of cilomilast and chlorogenic acid against scopolamine-induced memory deficits via modulation of the cAMP\/PKA-CREB-BDNF pathway","volume":"26","author":"Mosalam","year":"2025","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ibneur.2026.07.010_bib37","series-title":"Guide for the Care and Use of Laboratory Animals","article-title":"The National Academies Collection: Reports funded by National Institutes of Health","year":"2011"},{"key":"10.1016\/j.ibneur.2026.07.010_bib38","first-page":"93","article-title":"Schizophrenia induces oxidative stress and cytochrome C release in isolated rat brain mitochondria: a possible pathway for induction of apoptosis and neurodegeneration","volume":"13","author":"Faizi","year":"2014","journal-title":"Iran. J. Pharm. Res."},{"key":"10.1016\/j.ibneur.2026.07.010_bib39","doi-asserted-by":"crossref","first-page":"181","DOI":"10.3389\/fncel.2017.00181","article-title":"Glutamate Deregulation in Ketamine-Induced Psychosis-A Potential Role of PSD95, NMDA Receptor and PMCA Interaction","volume":"11","author":"Lisek","year":"2017","journal-title":"Front. Cell. Neurosci."},{"issue":"7","key":"10.1016\/j.ibneur.2026.07.010_bib40","doi-asserted-by":"crossref","DOI":"10.3390\/brainsci11070917","article-title":"Combined Low Dose of Ketamine and Social Isolation: A Possible Model of Induced Chronic Schizophrenia-Like Symptoms in Male Albino Rats","volume":"11","author":"Estaphan","year":"2021","journal-title":"Brain Sci."},{"key":"10.1016\/j.ibneur.2026.07.010_bib41","doi-asserted-by":"crossref","DOI":"10.1016\/j.fbio.2025.106244","article-title":"Chlorogenic acid, a dietary phenolic acid ameliorates hepatorenal injury in streptozotocin-induced diabetic rats through regulation of oxidative stress and inflammation","volume":"66","author":"Singh","year":"2025","journal-title":"Food Biosci."},{"key":"10.1016\/j.ibneur.2026.07.010_bib42","article-title":"Protective effect of chlorogenic acid on cognitive impairment in rats with early Alzheimer's disease via Wnt signaling pathway","volume":"9","author":"Wang","year":"2025","journal-title":"J. Alzheimers Dis. Rep."},{"key":"10.1016\/j.ibneur.2026.07.010_bib43","doi-asserted-by":"crossref","DOI":"10.1097\/FBP.0000000000000757","article-title":"Crocin (bioactive compound of Crocus sativus L.) potently restores REM sleep deprivation-induced manic- and obsessive-compulsive-like behaviors in female rats","author":"Houshyar","year":"2024","journal-title":"Behav. Pharmacol."},{"key":"10.1016\/j.ibneur.2026.07.010_bib44","article-title":"The effect of acute crocin on behavioral changes and BDNF expression level in socially isolated rats","author":"Kamaei","year":"2023","journal-title":"Naunyn Schmiede Arch. Pharmacol."},{"key":"10.1016\/j.ibneur.2026.07.010_bib45","article-title":"Striking long-term beneficial effects of single dose psilocybin and psychedelic mushroom extract in the SAPAP3 rodent model of OCD-like excessive self-grooming","author":"Brownstien","year":"2024","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.ibneur.2026.07.010_bib46","doi-asserted-by":"crossref","DOI":"10.1007\/s00210-024-03777-2","article-title":"BDNF and GSK-3beta expression changes underlie the beneficial effects of crocin on behavioral alterations in a rat model of autism induced by prenatal valproic acid administration","author":"Hosseini","year":"2025","journal-title":"Naunyn Schmiede Arch. Pharmacol."},{"key":"10.1016\/j.ibneur.2026.07.010_bib47","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1016\/j.neuroscience.2016.09.012","article-title":"Rodent models of obsessive compulsive disorder: Evaluating validity to interpret emerging neurobiology","volume":"345","author":"Zike","year":"2017","journal-title":"Neuroscience"},{"key":"10.1016\/j.ibneur.2026.07.010_bib48","doi-asserted-by":"crossref","DOI":"10.1016\/j.physbeh.2024.114718","article-title":"New insights into individual differences in response to chronic unpredictable mild stress (CUMS) in rats with respect to hippocampal BDNF and GSK3-beta expression levels","volume":"287","author":"Talaee","year":"2024","journal-title":"Physiol. Behav."},{"key":"10.1016\/j.ibneur.2026.07.010_bib49","doi-asserted-by":"crossref","DOI":"10.1016\/j.pbb.2025.174027","article-title":"Different protocols of REM sleep deprivation led to controversial effects on OCD- and anxiety-like behaviors and locomotor activity in fear conditioning male and female rats with respect to BDNF expression level","volume":"252","author":"Payamani","year":"2025","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.ibneur.2026.07.010_bib50","doi-asserted-by":"crossref","DOI":"10.1007\/s00213-024-06566-0","article-title":"Chronic REM sleep deprivation leads to manic- and OCD-related behaviors, and decreases hippocampal BDNF expression in female rats","author":"Abbasi","year":"2024","journal-title":"Psychopharmacol. (Berl. )"},{"key":"10.1016\/j.ibneur.2026.07.010_bib51","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2022.886514","article-title":"The effects of mango leaf extract during adolescence and adulthood in a rat model of schizophrenia","volume":"13","author":"Garcia-Partida","year":"2022","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.ibneur.2026.07.010_bib52","doi-asserted-by":"crossref","DOI":"10.1016\/j.pbb.2024.173894","article-title":"Synaptophysin and GSK-3beta activity in the prefrontal cortex may underlie the effects of REM sleep deprivation and lithium on behavioral functions and memory performance in male rats","volume":"245","author":"Gholami-Zanjanbar","year":"2024","journal-title":"Pharmacol. Biochem. Behav."},{"issue":"4","key":"10.1016\/j.ibneur.2026.07.010_bib53","article-title":"Maternal Supplementation with N-Acetylcysteine Modulates the Microbiota-Gut-Brain Axis in Offspring of the Poly I:C Rat Model of Schizophrenia","volume":"12","author":"Romero-Miguel","year":"2023","journal-title":"Antioxid. (Basel)"},{"key":"10.1016\/j.ibneur.2026.07.010_bib54","article-title":"Sex difference affects fear extinction but not lithium efficacy in rats following fear-conditioning with respect to the hippocampal level of BDNF","volume":"234","author":"Rahimi-Danesh","year":"2023","journal-title":"Pharmacol. Biochem. Behav."},{"issue":"4","key":"10.1016\/j.ibneur.2026.07.010_bib55","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1016\/S0278-5846(03)00080-0","article-title":"Ketamine-induced changes in rat behaviour: A possible animal model of schizophrenia","volume":"27","author":"Becker","year":"2003","journal-title":"Prog. Neuropsychopharmacol. Biol. Psychiatry"},{"issue":"7","key":"10.1016\/j.ibneur.2026.07.010_bib56","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1080\/j.1440-1614.2005.01626.x","article-title":"Importance of animal models in schizophrenia research","volume":"39","author":"van den Buuse","year":"2005","journal-title":"Aust. N. Z. J. Psychiatry"},{"issue":"2","key":"10.1016\/j.ibneur.2026.07.010_bib57","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1016\/0165-0173(94)00014-G","article-title":"The N-methyl-D-aspartate antagonists phencyclidine, ketamine and dizocilpine as both behavioral and anatomical models of the dementias","volume":"20","author":"Ellison","year":"1995","journal-title":"Brain Res. Brain Res. Rev."},{"issue":"3","key":"10.1016\/j.ibneur.2026.07.010_bib58","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1016\/j.neuroscience.2004.03.039","article-title":"Repeated application of ketamine to rats induces changes in the hippocampal expression of parvalbumin, neuronal nitric oxide synthase and cFOS similar to those found in human schizophrenia","volume":"126","author":"Keilhoff","year":"2004","journal-title":"Neuroscience"},{"key":"10.1016\/j.ibneur.2026.07.010_bib59","doi-asserted-by":"crossref","DOI":"10.47626\/1516-4446-2025-4301","article-title":"Prophylactic efficacy of cannabidiol and sodium nitroprusside in a ketamine-model of schizophrenia: sex-dependent effects on positive-like and cognitive impairments","author":"Prado","year":"2025","journal-title":"Braz. J. Psychiatry"},{"issue":"9","key":"10.1016\/j.ibneur.2026.07.010_bib60","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1177\/02698811211029739","article-title":"Impaired discrimination of a subanesthetic dose of ketamine in a maternal immune activation model of schizophrenia risk","volume":"35","author":"Meighan","year":"2021","journal-title":"J. Psychopharmacol."},{"issue":"5","key":"10.1016\/j.ibneur.2026.07.010_bib61","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1007\/s00213-023-06344-4","article-title":"Nano-hesperetin attenuates ketamine-induced schizophrenia-like symptoms in mice: participation of antioxidant parameters","volume":"240","author":"Moghaddam","year":"2023","journal-title":"Psychopharmacol. (Berl. )"},{"key":"10.1016\/j.ibneur.2026.07.010_bib62","doi-asserted-by":"crossref","DOI":"10.1016\/j.neulet.2021.136249","article-title":"Neuroprotective effects of curcumin-loaded nanophytosome on ketamine-induced schizophrenia-like behaviors and oxidative damage in male mice","volume":"765","author":"Moghaddam","year":"2021","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.ibneur.2026.07.010_bib63","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.schres.2025.03.031","article-title":"Cannabidiol reverses myeloperoxidase hyperactivity in the prefrontal cortex and striatum, and reduces protein carbonyls in the hippocampus in a ketamine-induced schizophrenia rat model","volume":"278","author":"de Almeida Queiroz","year":"2025","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.ibneur.2026.07.010_bib64","doi-asserted-by":"crossref","DOI":"10.1016\/j.neulet.2021.136354","article-title":"Effects of clozapine and risperidone antipsychotic drugs on the expression of CACNA1C and behavioral changes in rat 'Ketamine model of schizophrenia","volume":"770","author":"Azimi Sanavi","year":"2022","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.ibneur.2026.07.010_bib65","doi-asserted-by":"crossref","DOI":"10.1016\/j.pbb.2020.173042","article-title":"Sex-related differences in intravenous ketamine effects on dissociative stereotypy and antinociception in male and female rats","volume":"199","author":"Radford","year":"2020","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.ibneur.2026.07.010_bib66","first-page":"1","article-title":"Effect of acute administration of different ketamine doses on anxiety and metabolic activity of the amygdala in rats","author":"Guevara","year":"2025","journal-title":"Neuropsychobiology"},{"key":"10.1016\/j.ibneur.2026.07.010_bib67","doi-asserted-by":"crossref","DOI":"10.1016\/j.pbb.2023.173658","article-title":"Influence of the dose of ketamine used on schizophrenia-like symptoms in mice: A correlation study with TH, GAD(67), and PPAR-gamma","volume":"233","author":"Rodrigues","year":"2023","journal-title":"Pharmacol. Biochem. Behav."},{"issue":"3","key":"10.1016\/j.ibneur.2026.07.010_bib68","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1111\/jphp.13039","article-title":"Standardized extract of Erythrina velutina Willd. attenuates schizophrenia-Like behaviours and oxidative parameters in experimental animal models","volume":"71","author":"Dias","year":"2019","journal-title":"J. Pharm. Pharmacol."},{"key":"10.1016\/j.ibneur.2026.07.010_bib69","doi-asserted-by":"crossref","DOI":"10.1016\/j.pbb.2024.173950","article-title":"Ketamine impairs the performance of male mice in novel recognition object test and reduces the immunoreactivity of GAD(67) in the hippocampus: Role of pioglitazone","volume":"247","author":"Rodrigues","year":"2025","journal-title":"Pharmacol. Biochem. Behav."},{"issue":"2","key":"10.1016\/j.ibneur.2026.07.010_bib70","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1016\/j.pnpbp.2012.04.018","article-title":"Ketamine-enhanced immobility in forced swim test: a possible animal model for the negative symptoms of schizophrenia","volume":"38","author":"Chindo","year":"2012","journal-title":"Prog. Neuropsychopharmacol. Biol. Psychiatry"},{"issue":"1","key":"10.1016\/j.ibneur.2026.07.010_bib71","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1007\/s11033-025-10820-9","article-title":"Effects of cerebrolysin on behavioral changes and the tryptophan-kynurenine pathway in the prefrontal cortex of male mice in the ketamine model of schizophrenia","volume":"52","author":"Mafikandi","year":"2025","journal-title":"Mol. Biol. Rep."},{"issue":"1","key":"10.1016\/j.ibneur.2026.07.010_bib72","doi-asserted-by":"crossref","DOI":"10.1002\/jdn.10407","article-title":"Lutein Exerts Antioxidant and Neuroprotective Role on Schizophrenia-Like Behaviours in Mice","volume":"85","author":"Aziziha","year":"2025","journal-title":"Int. J. Dev. Neurosci."},{"key":"10.1016\/j.ibneur.2026.07.010_bib73","doi-asserted-by":"crossref","DOI":"10.5402\/2012\/595141","article-title":"Comparative evaluation of forced swim test and tail suspension test as models of negative symptom of schizophrenia in rodents","volume":"2012","author":"Chatterjee","year":"2012","journal-title":"ISRN Psychiatry"},{"issue":"3","key":"10.1016\/j.ibneur.2026.07.010_bib74","doi-asserted-by":"crossref","first-page":"1655","DOI":"10.1590\/0001-3765201720160844","article-title":"Is Forced Swimming Immobility a Good Endpoint for Modeling Negative Symptoms of Schizophrenia? - Study of Sub-Anesthetic Ketamine Repeated Administration Effects","volume":"89","author":"Neves","year":"2017","journal-title":"Acad. Bras. Cienc."},{"issue":"1","key":"10.1016\/j.ibneur.2026.07.010_bib75","doi-asserted-by":"crossref","first-page":"154","DOI":"10.5498\/wjp.v5.i1.154","article-title":"Brain-derived neurotrophic factor levels in first episode of psychosis: A systematic review","volume":"5","author":"Toll","year":"2015","journal-title":"World J. Psychiatry"},{"issue":"4","key":"10.1016\/j.ibneur.2026.07.010_bib76","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/j.eurpsy.2007.10.013","article-title":"Schizophrenia as a progressive brain disease","volume":"23","author":"van Haren","year":"2008","journal-title":"Eur. Psychiatry"},{"issue":"3","key":"10.1016\/j.ibneur.2026.07.010_bib77","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1007\/s12031-010-9447-5","article-title":"Phencyclidine (PCP)-induced disruption in cognitive performance is gender-specific and associated with a reduction in brain-derived neurotrophic factor (BDNF) in specific regions of the female rat brain","volume":"43","author":"Snigdha","year":"2011","journal-title":"J. Mol. Neurosci."},{"issue":"6","key":"10.1016\/j.ibneur.2026.07.010_bib78","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1038\/sj.mp.4001308","article-title":"Reduced brain-derived neurotrophic factor in prefrontal cortex of patients with schizophrenia","volume":"8","author":"Weickert","year":"2003","journal-title":"Mol. Psychiatry"},{"issue":"6","key":"10.1016\/j.ibneur.2026.07.010_bib79","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1016\/j.eurpsy.2004.06.020","article-title":"Neurotrophic factors and the pathophysiology of schizophrenic psychoses","volume":"19","author":"Durany","year":"2004","journal-title":"Eur. Psychiatry"},{"issue":"9","key":"10.1016\/j.ibneur.2026.07.010_bib80","doi-asserted-by":"crossref","first-page":"1108","DOI":"10.1038\/mp.2014.117","article-title":"Peripheral brain-derived neurotrophic factor in schizophrenia and the role of antipsychotics: meta-analysis and implications","volume":"20","author":"Fernandes","year":"2015","journal-title":"Mol. Psychiatry"},{"issue":"4","key":"10.1016\/j.ibneur.2026.07.010_bib81","doi-asserted-by":"crossref","DOI":"10.1016\/j.jsps.2024.101994","article-title":"NMDA receptor modulation by Esculetin: Investigating behavioral, biochemical and neurochemical effects in schizophrenic mice model","volume":"32","author":"Khalid","year":"2024","journal-title":"Saudi Pharm. J."},{"issue":"3","key":"10.1016\/j.ibneur.2026.07.010_bib82","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1007\/s11064-022-03808-5","article-title":"Reversal and preventive pleiotropic mechanisms involved in the antipsychotic-like effect of taurine, an essential beta-amino acid in ketamine-induced experimental schizophrenia in mice","volume":"48","author":"Ben-Azu","year":"2023","journal-title":"Neurochem. Res."},{"key":"10.1016\/j.ibneur.2026.07.010_bib83","doi-asserted-by":"crossref","DOI":"10.1007\/s00210-025-03912-7","article-title":"Brain-derived neurotrophic factor (BDNF) changes in rodent models of schizophrenia induced by ketamine: a systematic review","author":"Motamedi-Manesh","year":"2025","journal-title":"Naunyn Schmiede Arch. Pharmacol."},{"key":"10.1016\/j.ibneur.2026.07.010_bib84","doi-asserted-by":"crossref","DOI":"10.1016\/j.brainresbull.2023.110796","article-title":"Antidepressant effects of 70% ethanolic extract of Lonicerae japonicae flos and it contained chlorogenic acid via upregulation of BDNF-TrkB pathway in the hippocampus of mice","volume":"204","author":"Qin","year":"2023","journal-title":"Brain Res. Bull."},{"issue":"1","key":"10.1016\/j.ibneur.2026.07.010_bib85","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1007\/s12035-024-04299-x","article-title":"Neuroprotective effect of chlorogenic acid in an animal model of sporadic Alzheimer's disease induced by streptozotocin","volume":"62","author":"Bezerra","year":"2025","journal-title":"Mol. Neurobiol."}],"container-title":["IBRO Neuroscience Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2667242126001119?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2667242126001119?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T16:44:40Z","timestamp":1793810680000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2667242126001119"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,12]]},"references-count":85,"alternative-id":["S2667242126001119"],"URL":"https:\/\/doi.org\/10.1016\/j.ibneur.2026.07.010","relation":{},"ISSN":["2667-2421"],"issn-type":[{"value":"2667-2421","type":"print"}],"subject":[],"published":{"date-parts":[[2026,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Investigating the effects of chlorogenic acid on novel object recognition memory impairment, hyperlocomotion, and prefrontal BDNF expression in a sub-chronic ketamine-induced schizophrenia-like rat model","name":"articletitle","label":"Article Title"},{"value":"IBRO Neuroscience Reports","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ibneur.2026.07.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Inc. on behalf of International Brain Research Organization.","name":"copyright","label":"Copyright"}]}}